183 related articles for article (PubMed ID: 21054129)
1. System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer.
Swartling J; Axelsson J; Ahlgren G; Kälkner KM; Nilsson S; Svanberg S; Svanberg K; Andersson-Engels S
J Biomed Opt; 2010; 15(5):058003. PubMed ID: 21054129
[TBL] [Abstract][Full Text] [Related]
2. Online dosimetry for temoporfin-mediated interstitial photodynamic therapy using the canine prostate as model.
Swartling J; Höglund OV; Hansson K; Södersten F; Axelsson J; Lagerstedt AS
J Biomed Opt; 2016 Feb; 21(2):28002. PubMed ID: 26886806
[TBL] [Abstract][Full Text] [Related]
3. Realtime light dosimetry software tools for interstitial photodynamic therapy of the human prostate.
Johansson A; Axelsson J; Andersson-Engels S; Swartling J
Med Phys; 2007 Nov; 34(11):4309-21. PubMed ID: 18072496
[TBL] [Abstract][Full Text] [Related]
4. Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer.
Verigos K; Stripp DC; Mick R; Zhu TC; Whittington R; Smith D; Dimofte A; Finlay J; Busch TM; Tochner ZA; Malkowicz S; Glatstein E; Hahn SM
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):373-87. PubMed ID: 16566729
[TBL] [Abstract][Full Text] [Related]
5. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
Moore CM; Nathan TR; Lees WR; Mosse CA; Freeman A; Emberton M; Bown SG
Lasers Surg Med; 2006 Jun; 38(5):356-63. PubMed ID: 16392142
[TBL] [Abstract][Full Text] [Related]
6. In vivo photosensitizer tomography inside the human prostate.
Axelsson J; Swartling J; Andersson-Engels S
Opt Lett; 2009 Feb; 34(3):232-4. PubMed ID: 19183615
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study.
Nathan TR; Whitelaw DE; Chang SC; Lees WR; Ripley PM; Payne H; Jones L; Parkinson MC; Emberton M; Gillams AR; Mundy AR; Bown SG
J Urol; 2002 Oct; 168(4 Pt 1):1427-32. PubMed ID: 12352410
[TBL] [Abstract][Full Text] [Related]
8. Optical properties of human prostate at 732 nm measured in mediated photodynamic therapy.
Zhu TC; Dimofte A; Finlay JC; Stripp D; Busch T; Miles J; Whittington R; Malkowicz SB; Tochner Z; Glatstein E; Hahn SM
Photochem Photobiol; 2005; 81(1):96-105. PubMed ID: 15535736
[TBL] [Abstract][Full Text] [Related]
9. Treatment planning and dose analysis for interstitial photodynamic therapy of prostate cancer.
Davidson SR; Weersink RA; Haider MA; Gertner MR; Bogaards A; Giewercer D; Scherz A; Sherar MD; Elhilali M; Chin JL; Trachtenberg J; Wilson BC
Phys Med Biol; 2009 Apr; 54(8):2293-313. PubMed ID: 19305043
[TBL] [Abstract][Full Text] [Related]
10. Laser dosimetry studies in the prostate.
Chen Q; Hetzel FW
J Clin Laser Med Surg; 1998 Feb; 16(1):9-12. PubMed ID: 9728124
[TBL] [Abstract][Full Text] [Related]
11. Photodynamic therapy for prostate cancer--a review of current status and future promise.
Moore CM; Pendse D; Emberton M
Nat Clin Pract Urol; 2009 Jan; 6(1):18-30. PubMed ID: 19132003
[TBL] [Abstract][Full Text] [Related]
12. Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: assessment of safety and treatment response.
Trachtenberg J; Bogaards A; Weersink RA; Haider MA; Evans A; McCluskey SA; Scherz A; Gertner MR; Yue C; Appu S; Aprikian A; Savard J; Wilson BC; Elhilali M
J Urol; 2007 Nov; 178(5):1974-9; discussion 1979. PubMed ID: 17869307
[TBL] [Abstract][Full Text] [Related]
13. Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements.
Thompson MS; Johansson A; Johansson T; Andersson-Engels S; Svanberg S; Bendsoe N; Svanberg K
Appl Opt; 2005 Jul; 44(19):4023-31. PubMed ID: 16004049
[TBL] [Abstract][Full Text] [Related]
14. [Local curative treatment of superficial adenocarcinoma in Barrett's esophagus. First results of photodynamic therapy with a new photosensitizer].
Etienne J; Dorme N; Bourg-Heckly G; Raimbert P; Fékété F
Bull Acad Natl Med; 2000; 184(8):1731-44; discussion 1744-7. PubMed ID: 11471391
[TBL] [Abstract][Full Text] [Related]
15. Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm.
Altschuler MD; Zhu TC; Li J; Hahn SM
Med Phys; 2005 Dec; 32(12):3524-36. PubMed ID: 16475751
[TBL] [Abstract][Full Text] [Related]
16. Vascular-targeted photodynamic therapy (padoporfin, WST09) for recurrent prostate cancer after failure of external beam radiotherapy: a study of escalating light doses.
Trachtenberg J; Weersink RA; Davidson SR; Haider MA; Bogaards A; Gertner MR; Evans A; Scherz A; Savard J; Chin JL; Wilson BC; Elhilali M
BJU Int; 2008 Aug; 102(5):556-62. PubMed ID: 18494829
[TBL] [Abstract][Full Text] [Related]
17. Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: clinical experience and practicalities.
Weersink RA; Bogaards A; Gertner M; Davidson SR; Zhang K; Netchev G; Trachtenberg J; Wilson BC
J Photochem Photobiol B; 2005 Jun; 79(3):211-22. PubMed ID: 15896648
[TBL] [Abstract][Full Text] [Related]
18. Light dosimetry for multiple cylindrical diffusing sources for use in photodynamic therapy.
Dickey DJ; Partridge K; Moore RB; Tulip J
Phys Med Biol; 2004 Jul; 49(14):3197-208. PubMed ID: 15357192
[TBL] [Abstract][Full Text] [Related]
19. Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.
Krueger T; Altermatt HJ; Mettler D; Scholl B; Magnusson L; Ris HB
Lasers Surg Med; 2003; 32(1):61-8. PubMed ID: 12516073
[TBL] [Abstract][Full Text] [Related]
20. Preclinical studies in normal canine prostate of a novel palladium-bacteriopheophorbide (WST09) photosensitizer for photodynamic therapy of prostate cancers.
Chen Q; Huang Z; Luck D; Beckers J; Brun PH; Wilson BC; Scherz A; Salomon Y; Hetzel FW
Photochem Photobiol; 2002 Oct; 76(4):438-45. PubMed ID: 12405153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
